Patents by Inventor Sehhoon PARK

Sehhoon PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CXCL13 Marker For Predicting Immunotherapeutic Responsiveness In Patient With Lung Cancer And Use Thereof
    Publication number: 20210363593
    Abstract: The present invention relates to a biomarker for predicting immunotherapy responsiveness in a patient with lung cancer and a use thereof, and more specifically, to a marker composition for predicting immunotherapy responsiveness in a patient with lung adenocarcinoma, a composition for predicting immunotherapy responsiveness, and a method for providing information for predicting immunotherapy responsiveness, comprising a CXCL13 gene or a protein encoded by the gene, and it was confirmed that CXCL3 was significantly upregulated in a patient administered an immune checkpoint inhibitor using the composition of the present invention, and through this, the CXCL13 gene or the protein encoded by the gene may be usefully used as a marker for predicting anticancer drug therapy responsiveness against lung cancer in related research fields, and is expected to be utilized as an immunotherapeutic adjuvant which enhances the anticancer treatment effect by developing an enhancer.
    Type: Application
    Filed: October 28, 2020
    Publication date: November 25, 2021
    Inventors: Se Hoon LEE, Sehhoon PARK, Hong Sook KIM, Hongui CHA